Literature DB >> 18497097

The fibroblast growth factor family and mood disorders.

H Akil1, S J Evans, C A Turner, J Perez, R M Myers, W E Bunney, E G Jones, S J Watson.   

Abstract

While there has been a great deal of interest in the role of brain-derived neurotrophic factor (BDNF) in mood disorders and/or the mode of action of antidepressants, less is known about the role of other growth factors. This paper is focused on a group of growth factors, the fibroblast growth factor (FGF) family and their potential role in mood disorders.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18497097     DOI： 10.1002/9780470751251.ch8

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN： 1528-2511


  10 in total

Review 1.  Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents.

Authors:  Ronald S Duman; Bhavya Voleti
Journal:  Trends Neurosci       Date:  2012-01       Impact factor: 13.837

Review 2.  A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists.

Authors:  Ronald S Duman; Nanxin Li
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-09-05       Impact factor: 6.237

3.  Short-hairpin RNA silencing of endogenous fibroblast growth factor 2 in rat hippocampus increases anxiety behavior.

Authors:  Emine Eren-Koçak; Cortney A Turner; Stanley J Watson; Huda Akil
Journal:  Biol Psychiatry       Date:  2011-01-07       Impact factor: 13.382

4.  Antidepressant effects of fibroblast growth factor-2 in behavioral and cellular models of depression.

Authors:  Maha Elsayed; Mounira Banasr; Vanja Duric; Neil M Fournier; Pawel Licznerski; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2012-04-17       Impact factor: 13.382

5.  Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse.

Authors:  Klementina Fon Tacer; Angie L Bookout; Xunshan Ding; Hiroshi Kurosu; George B John; Lei Wang; Regina Goetz; Moosa Mohammadi; Makoto Kuro-o; David J Mangelsdorf; Steven A Kliewer
Journal:  Mol Endocrinol       Date:  2010-07-28

6.  Fibroblast Growth Factor 2 Modulates Hypothalamic Pituitary Axis Activity and Anxiety Behavior Through Glucocorticoid Receptors.

Authors:  Natalina Salmaso; Hanna E Stevens; Jessica McNeill; Maha ElSayed; Qiuyin Ren; Maria E Maragnoli; Michael L Schwartz; Simone Tomasi; Robert M Sapolsky; Ronald Duman; Flora M Vaccarino
Journal:  Biol Psychiatry       Date:  2016-03-02       Impact factor: 13.382

7.  A new role for FGF2 as an endogenous inhibitor of anxiety.

Authors:  Javier A Perez; Sarah M Clinton; Cortney A Turner; Stanley J Watson; Huda Akil
Journal:  J Neurosci       Date:  2009-05-13       Impact factor: 6.167

8.  Significantly higher peripheral fibroblast growth factor-2 levels in patients with major depressive disorder: A preliminary meta-analysis under MOOSE guidelines.

Authors:  Ching-Kuan Wu; Ping-Tao Tseng; Yen-Wen Chen; Kun-Yu Tu; Pao-Yen Lin
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

9.  Looking at cerebellar malformations through text-mined interactomes of mice and humans.

Authors:  Ivan Iossifov; Raul Rodriguez-Esteban; Ilya Mayzus; Kathleen J Millen; Andrey Rzhetsky
Journal:  PLoS Comput Biol       Date:  2009-11-06       Impact factor: 4.475

10.  Fibroblast growth factor 2 is necessary for the antidepressant effects of fluoxetine.

Authors:  Stephanie Simard; Pragya Shail; Jessica MacGregor; Maha El Sayed; Ronald S Duman; Flora M Vaccarino; Natalina Salmaso
Journal:  PLoS One       Date:  2018-10-01       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.